Trial Profile
A Phase I Trial of Peptide T: Efficacy for the Neuropsychiatric Complications of Acquired Immunodeficiency Syndrome (AIDS).
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 03 Nov 2021
Price :
$35
*
At a glance
- Drugs Peptide T (Primary)
- Indications HIV infections
- Focus Adverse reactions
- 13 Oct 2005 New trial record.